Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-13

FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for balsalazide disodium from Hikma Pharmaceuticals USA Inc., confirming continued approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BALSALAZIDE DISODIUM (balsalazide disodium)

Snippet

SUPPL AP for BALSALAZIDE DISODIUM (BALSALAZIDE DISODIUM)